Allurion Technologies Archives - Medical Design Sourcing

UK NHS trust treats first patients with Allurion weight loss balloon

The Allurion Program. [Image courtesy of Allurion]Allurion (NYSE:ALUR) announced today that the Somerset NHS Foundation Trust introduced its gastric balloon for weight loss.

This marks the first NHS trust in the UK and the first non-private sector organization in the world to introduce the balloon.

Natick Massachusetts-based Allurion designed the swallowable balloon to require no surgery, endoscopy or anaesthesia. Once swallowed, the balloon fills and remains in the stomach for approximately four months before self-emptying and passing out naturally.

According to a news release, the balloon demonstrated an average of 10%-15% body weight loss after approximately four months. Studies show that, on average, patients can sustain 96% of their weight loss one year after the balloon passes.

Allurion offers a program that combines its balloon with the Allurion Virtual Care Suite. The company said its balloon is the world’s first and only swallowable, procedu…

Weight loss balloon maker Allurion goes public on NYSE through SPAC merger

The Allurion Program. [Image courtesy of Allurion]Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange.

Natick, Massachusetts-based Allurion went public on Aug. 2 under the ALUR ticker. The business combination took place with Compute Health Acquisition Corp, a special purpose acquisition company (SPAC).

Allurion develops an artificial intelligence-powered weight loss program. Its program combines its Allurion Balloon with the Allurion Virtual Care Suite. The company said its balloon is the world’s first and only swallowable, procedure-less gastric balloon for weight loss. Its Iris platform powers the Virtual Care Suite, a remote patient monitoring solution. The company also offers the Virtual Care Suite as a standalone product.

Earlier this year, the company teamed up with Medtronic to pursue AI-based weight loss treatments.

“Since day one at Allurion, we have been dedicated to ending obesi…

Medtronic, Allurion partner on AI-based weight loss tech

The Allurion Program. [Image courtesy of Allurion]Allurion announced today that it entered into a pilot collaboration with Medtronic (NYSE: MDT) + .

Allurion and Medtronic inked a sales agency agreement in the Central and Eastern Europe, Middle East, and Africa (CEMA) region. The agreement aims to expand access to Allurion’s artificial intelligence-powered weight loss program. It enables Allurion to offer its Allurion Balloon and accelerate the utilization of its Iris AI platform. The company aims to leverage Medtronic’s channels to enhance the management of bariatric surgery patients.

Natick, Massachusetts-based Allurion’s program combines its Allurion Balloon with the Allurion Virtual Care Suite. The company said its balloon is the world’s first and only swallowable, procedure-less gastric balloon for weight loss. Its Iris platform powers the Virtual Care Suite, a remote patient monitoring solutio…